All Episodes
Business Of Biotech — 324 episodes
Biotech Finance And Investor Update With Independent Board Director Allan Shaw
Funding A Virtual Biotech Without Institutional Capital With Sarcomatrix's David Craig
Picking Biotech Winners Beyond The Hype Cycle With Andera Partners' Olivier Litzka
Biotech Investing At The Earliest Stages With Santé Ventures' Omar Khalil
Getting To A First Product Approval With Celcuity's Brian Sullivan
Cell Therapy Advances And Biotech Leadership With Nkarta's Paul Hastings
A Rescue Model For Shelved Drug Candidates With Annette Bakker, Ph.D. And Andrew Lo, Ph.D.
Using Genetics To Discover New Treatments With Regeneron Genetics Center's Aris Baras, M.D.
Late-Stage Development And Commercial Planning With CervoMed's Matt Winton, Ph.D.
BoB@BIO: Biotech In The Balance With Ovid Therapeutics' Dr. Jeremy Levin
BoB@BIO: Biotech Investing And Deals With Sofinnova's Maha Radhakrishnan, M.D.
Targeting Tau in Alzheimer's Disease With Voyager Therapeutics' Al Sandrock, M.D., Ph.D.
Keeping An Early-Stage Cell Therapy Biotech In The Black With IN8bio's William Ho
Drug Launch Success In A Changing Commercial Landscape With ACMA's William Soliman, Ph.D.
The Editors' Roundtable: A Midyear Look At The 2026 Life Sciences Industry
Derisking CNS Drug Development With Tortugas Neuroscience's Jeff Jonas, M.D.
Rare Disease Drug Commercialization With Zevra Therapeutics' Neil McFarlane
Scaling Manufacturing For Personalized Cell Therapies With Cellino's Marinna Madrid, Ph.D.
Building A New Antibody Discovery Platform With Infinimmune's Wyatt McDonnell, Ph.D.
From Partnered ASO Therapies To A Wholly-Owned Pipeline With Ionis's Brett Monia, Ph.D.
Implementing A New CEO Strategy With NervGen's Adam Rogers, M.D. And Rich Macary
The Impact Of FDA Risk On Biotech Rewards With CFO And Board Director Allan Shaw
Biosimilars And Complex Medicines For All With RNA Therapeutics' Sarfaraz Niazi, Ph.D.
Radiotherapeutics For Neuroendocrine Tumors With Perspective Therapeutics' Thijs Spoor
Investing In Early-Stage Oncology With Yosemite's Dan McHugh
Commercializing CAR T Cell Therapy With Legend Biotech's Alan Bash
Radiotherapeutics For CNS Cancers With Plus Therapeutics' Marc Hedrick, M.D.
Developing Novel Cancer Drugs On A Budget With Iterion Therapeutics' Rahul Aras, Ph.D.
Making Biologics Orally Available With Vivtex's Thomas von Erlach, Ph.D.
An Anthropological Lens On Leadership In Life Sciences With Bunka's Monika Sumra, Ph.D.
Company Turnarounds And AI For Infectious Diseases With Seek Labs' Jared Bauer
Bringing Curative Cell Therapies To Market with Kite Pharma's Cindy Perettie
BoB@JPM: Brian Hilberdink, Boehringer Ingelheim
BoB@JPM: Ron Cooper, enGene
BoB@JPM: Marc Salzberg, M.D., Airway Therapeutics
A Royalty Model For Value Creation With Zymeworks' Kenneth Galbraith
Life Science Connect Editors' Roundtable: Wrapping Up 2025 And Looking Ahead
Building Cell Therapy Companies With Kenai Therapeutics' Nick Manusos
Modernizing Clinical Trial Operations With Merck's Jennifer Sheller
Transforming Chronic Kidney Disease With ProKidney's Bruce Culleton, M.D.
Engineering B Cells With Immusoft's Sean Ainsworth
Building A Cancer Pipeline In A Molecule With Actuate Therapeutics' Dan Schmitt
Biotech Collaboration Strategy With IGI's Cyril Konto, M.D.
Biotech Funding And IPO Temperature Check With Create Medicine's Allan Shaw
Funding Tips And Moving From R&D To Commercial With Madrigal Pharmaceuticals' Mardi Dier
Emerging From Stealth With Vima Therapeutics' Bernard Ravina, M.D.
BoB in South Florida: Rich Daly, Catalyst Pharmaceuticals
BoB In South Florida: Anthony Japour, M.D., iTolerance
BoB In South Florida: Daniel Teper, NAYA Therapeutics
BoB In South Florida: Raquel Cabo, Miami Biotech Collective
The Business Case For Health Economics And Outcomes Research With ISPOR's Rob Abbott
Cannabinoid And Psychedelic Combinations With Incannex Healthcare's Joel Latham
Dye Drug Conjugates For Cancer With Lahjavida's Lyle Small
Investing In The Biostack With Modi Ventures' Sahir Ali, Ph.D.
Improving Cardiovascular Outcomes With Immediate Therapeutics' Atul Deshpande, Ph.D.
Building A Biotech Incubator And Accelerator With Swiss Rockets Founder And CEO Vladimir Cmiljanovic, Ph.D.
Biotech Product Partnership with Coya Therapeutics' Arun Swaminathan, Ph.D. and Dr. Reddy's Milan Kalawadia
How To Hire And Build A Winning Executive Team With Occam Global's Bill Holodnak
The Generalist Biotech CEO With Seekyo's Oury Chetboun
Innovating On The Frontier Of Radiopharmaceuticals With RadioMedix's Ebrahim Delpassand, M.D.
Building An Efficient Biopharma With South Rampart Pharma's Hernan Bazan, M.D.
The Business And Science Of Obesity With Roger Cone, Ph.D., Founder Of Courage Therapeutics
BoB Live At BIO: Amber Salzman, Ph.D., Epicrispr Biotechnologies
How To Be A Policy Advocate For Biotech With NewYorkBIO's Jennifer Hawks Bland
FDA Trials And Tribulations With Connect Biopharma's Barry Quart
Proactive Procurement Strategies For Biotech With Tom Wells
The Discovery Of Microbes And Implications For Public Health Today, With Science Writer Thomas Levenson
Psychedelics For Mental Health Disorders With atai's Srinivas Rao, M.D., Ph.D.
Biotech Angel Investing With Yaniv Sneor
Leading A tRNA Startup With Alltrna's Michelle Werner
Executing A Product Pivot With Vir Bio's Mark Eisner, MD
Commercializing RNAi Therapies With Alnylam's Tolga Tanguler
Big Pharma Insights For Building Biotech Startups With Uniquity Bio's Brian Lortie
The Implications Of China's Growing Biotech Industry With Allan Shaw
How To Be A CFO With Insmed's Sara Bonstein
Deal And Investment Trends With Investment Banker David Sans
Business of Biotech 2.0 with Ben Comer
BoB@JPM: Nima Farzan, Latigo Biotherapeutics
BoB@JPM: Kasper Roet, Ph.D., QurAlis
BoB@JPM: Rick Modi, Affinia Therapeutics
BoB@JPM: Owen Hughes & Brad Sitko, XOMA Royalty
BoB@JPM: Tom Chalberg, Ph.D., Genascence
BoB@JPM: Ran Zheng, Landmark Bio
BoB@JPM: Peter Anastasiou, Capsida Biotherapeutics
BoB@JPM: Stefan Scherer, M.D., Ph.D., 3T Bioscience
The Business Of CNS with Acumen's Jim Doherty, Ph.D.
High-Throughput Discovery With Bioptic's Andrey Dobry
RNA Sandbox with Johns Hopkins RNA Innovation Center's Jeff Coller, Ph.D. and Michelle Kim, Ph.D.
Biotech Story Time With Tal Zaks, M.D. (Part 2, Tall Tales with Tal)
Risk Mitigation With Meira GTx's Zandy Forbes, Ph.D.
Biotech Story Time With Tal Zaks, M.D. (Part 1)
A $1B AI Bet With Foresite Labs' Vik Bajaj, Ph.D.
Manufacturing Partnership With Life Biosciences' Jerry McLaughlin and Forge Biologics' John Maslowski
Novel Peptide Delivery With Revolo's Woody Bryan, Ph.D.
Biopolitics With Allan Shaw
T-Cells For The Win With Adaptimmune's Adrian Rawcliffe
Serving The Underserved With Gates MRI's Claire Wagner, M.D.
An Unanticipated Biotech Startup With OS Therapies' Paul Romness
Building On Pandemic Progress With Barinthus Biotherapeutics' Bill Enright
Obesity Tx End-Around With Skye Bioscience's Punit Dhillon
Biotech C-Suite Construction With Allan Shaw
The Peptide Promise With NervGen's Mike Kelly
Biotech Course Correction With Treehill Partners' Ali Pashazadeh
An AI Awakening With Profluent Bio's Hilary Eaton, Ph.D.
Picking Biotech Jockeys With SR One's Simeon George, M.D.
Embracing Biotech Chaos With Memo's Erik van den Berg
Pivoting To RNA With Circio's Dr. Erik Digman Wiklund
mRNA Upstarts With Radar Therapeutics' Sophia Lugo and Eerik Kaseniit, Ph.D.
Steering Through Setbacks with AVEO Oncology's Michael Bailey
Leading From Within with ISCT & Kiji's Miguel Forte, M.D.
The Allogeneic Future with Poseida's Kristin Yarema, Ph.D.
Expanding The Proteome with ProFound's John Lepore, M.D.
From The Bench To The Boardroom with ImmunityBio's Enrique Diloné
First AI Antibody In Humans with Aulos' Aron Knickerbocker
Drug Delivery Differentiators with Syncromune's Eamonn Hobbs
Topical Ocular Biologics with Claris Bio's Clarke Atwell
C&G Regulatory Guidance with Lineage Therapeutics' Brian Culley
True DEI Value in Biopharma with Arcellx's Rami Elghandour
Mission-Driven Dementia Funding with DDF's Jonathan Behr
ADCs Ignited with Daiichi Sankyo Inc.'s Ken Keller
Accelerating ADCs with Mythic Therapeutics' Brian Fiske, Ph.D.
The Anti-CDMO with CTMC's Jason Bock, Ph.D. and KSQ's Thomas Leitch
A New Prescription For PBMs with Allan Shaw
New Apps For AI in mRNA With Anima Biotech's Yochi Slonim
Circular RNA with Orna Therapeutics' Tom Barnes, Ph.D. and Advancing RNA's Anna Rose Welch
Physician + Biotech Builder with Tome Biosciences' Rahul Kakkar, M.D.
Commercial Readiness with ImmunityBio's Bobby Reddy, M.D.
Precision Drug Delivery with Ampersand Biomedicines' Jason Gardner, D.Phil.
Funding Alzheimer's Tx Dev with ADDF's Karen Harris
The AI Impact with Generate:Biomedicines' Mike Nally
Strategic Deals with CinRx's Gavin Samuels, M.D.
Serial Success With Triumvira's Rob Williamson
The Innovator's Dilemma with Lumen Bioscience's Brian Finrow, J.D.
Precision Radiopharmaceuticals with Ratio's Jack Hoppin, Ph.D.
Managing Mergers With Sail Biomedicines' Guillaume Pfefer, Ph.D.
Reprogramming Human Cells With bit.bio's Mark Kotter, M.D.
Inhalable mRNA with Ethris' Carsten Rudolph, Ph.D.
Biotech Is Back with Allan Shaw
Multimodal R&D Management with Incyte's Jim Lee, M.D., Ph.D.
Building A Biotech Hub with Intellia Therapeutics' John Leonard, M.D.
Art Of The Pivot with Elevation Oncology's Joe Ferra
CDMO Collab with Scorpius BioManufacturing's Steve Lavezoli + Fina Biosolutions' Dr. Andrew Lees
Biotech Down Under with BiomeBank's Dr. Sam Costello
IL-2 Program Profits with Bonum's Drs. John Mulligan and Neela Patel
Public Sector Forged, Private Sector Tested with Renovaro BioSciences' Mark Dybul, M.D.
mRNA Vaccine Platforms with Combined Therapeutics' Dr. Romain Micol
Biotech Dealmaking with Regeneron's Nouhad Husseini
Backpacks And Biotech with Luke Timmerman
RNA Delivery Business with Liberate's Shawn Davis, Ph.D. & Walter Strapps, Ph.D.
The Legendary Steve Gorlin's Golden Rules
UPCOMING SPECIAL: Unraveling Biotech's Legal Enigmas With Keir LoIacono
CDMO + Emerging Bio Partnership with Forge's John Maslowski and Ray's Jenny Holt
Clinical Leadership with Cue Biopharma's Anish Suri, Ph.D. & Dan Passeri, J.D.
Bio Career Moves with Codagenix's Johanna Kaufmann, Ph.D.
Veteran Advice From The C-Suite with Citius' Leonard Mazur
Don't Be A D**k with Ochre Bio's Quin Wills, M.D., Ph.D.
Pragmatic Computational Biology with Andrew Satz
Commercial Readiness with Orca Bio's Dan Kirby
Bio & The Business Of Aging with Life Biosciences' Jerry McLaughlin
Fiscal Turnarounds with Protalix's Eyal Rubin
Building LEO Pharma's U.S. Presence with Brian Hilberdink
Managing Momentum With Rezolute Bio's Nevan Charles Elam, JD
Facing NASH Therapeutic Skepticism with 89bio's Rohan Palekar
Biotech Cash Management with Allan Shaw
Establishing Research With Horizon Therapeutics' Robert Stoffel, Ph.D.
Surviving The Microbiome Market with MaaT Pharma's Hervé Affagard
COO Liftoff With Rocket Pharmaceuticals' Kinnari Patel, PharmD
ML-Enabled Drug Discovery With LabGenius' James Field, Ph.D.
Biopharma Comebacks With Vincerx's Ahmed Hamdy, MD
Origins Of A Biopharma VC Deal With Bernat Olle, Ph.D. and Parag Shah
Population-Level Health Impact With Vaxxinity's John Krayacich
The Face Of African Biotech with Adrienne Leussa, Ph.D.
The Innovation Reduction Act with Allan Shaw
Propagating Peptides With Peptilogics' Jonathan Steckbeck, Ph.D.
Resilient Biopharma Leadership With Ambrx's Dan O'Connor
Funding A Neurodegeneration Startup With Coya Therapeutics' Howard Berman
A More NIIMBL Biotech Workforce With John Balchunas
Building Flagship Pioneering With Avak Kahvejian, Ph.D.
Therapeutic Molecules From Moss with eleva's Andreas Schaaf and Björn Cochlovius, Ph.D.
Gene Tx For Hearing Loss with Sensorion's Nawal Ouzren
Functional Ectopic Organs with LyGenesis' Michael Hufford, Ph.D.
Approvals & Mergers: Inside Enzyvant with Bill Symonds, Pharm.D.
Next-Gen Nanobodies With MoonLake's Jorge Santos Da Silva, Ph.D.
Lessons From The Bone Therapeutics/Medsenic Merger With BioSenic's François Rieger, Ph.D.
TCRs In Personalized Oncology With BlueSphere Bio's Keir Loiacono
BoB@JPM: Self-Replicating RNA With Elixirgen's Akihiro Ko
BoB@JPM: Gene Writing With Tessera's Michael Severino, M.D.
BoB@JPM: Post-IPO With Bolt Biotherapeutics' Drs. Randall Schatzman and Edith Perez
BoB@JPM: Academia To Industry With Oncolytics' Matt Coffey, Ph.D.
BoB@JPM: Support Of A Blossoming Pipeline With Sangamo's Sandy Macrae, Ph.D.
Building A Better COVID Vaccine With Ocugen's Shankar Musunuri, Ph.D.
Modality-Agnostic Drug Discovery With Cullinan Oncology's Nadim Ahmed
Women In Biotech With Bill & Melinda Gates MRI's Piper Trelstad, Ph.D.
Computational Drug Discovery With Gain Therapeutics' Matthias Alder
Dissecting Spesolimab's Approval With Boehringer Ingelheim's Carine Boustany
AI & Computational Biology With Recursion's Chris Gibson, Ph.D.
Allan Shaw On Financing Biopharma Innovation
Gene Therapy For Chronic Inflammation With Xalud's Howard Rutman, M.D.
The Antibody Engine With Abpro's Chan Brothers
In-Vivo CAR T Update With Umoja Biopharma's David Fontana, Ph.D.
RNA-Based Therapeutics With Nutcracker Therapeutics' Dr. Geoff Nosrati
Tick-Derived Therapeutic Molecules With Akari Therapeutics' Rachelle Jacques
Product vs. Platform With Surface's Vito Palombella, Ph.D. and Robert Ross, M.D.
Leveraging Lymph Nodes With Elicio's Dr. Peter DeMuth
Engineering Proteins For Food Allergies With Ukko's Dr. Anat Binur
Anatomy Of A VC Deal With 4BIO's Dima Kuzmin & Ray Therapeutics' Paul Bresge
Oncology Discovery Advances With AbbVie's Steve Davidsen, Ph.D.
IND For TIL Therapy With Obsidian Therapeutics' Paul Wotton, Ph.D.
Regenerative Wound Care With BioStem Technologies' Jason Matuszewski & Andrew VanVurst
Epigenomic Programming With Omega Therapeutics' Mahesh Karande
IDO Target Perseverence With IO Biotech's Mai-Britt Zocca, Ph.D.
Pursuit Of A Universal Flu Vaccine With Longhorn Vaccines & Diagnostics' Jeff Fischer
Genetic Testing & Neurodegenerative Disorders With AviadoBio's Lisa Deschamps
Biotech M&A Anomalies With Allan Shaw
Observations On Outsourcing With Molecule to Market's Raman Sehgal
What's A Biologic Revolution? With Vaxxinity's Mei Mei Hu, J.D.
Creative Capital Generation With James Thomas Coates, Ph.D.
Oligonucleotide Opportunities in DMD with PepGen's James McArthur, Ph.D.
Changing The Diabetes Care Paradigm With Arecor's Dr. Sarah Howell
Innate Immunity & Mouse Models With LIfT Biosciences' Alex Blyth
Antibody Cocktails With Immunome's Dr. Purnanand Sarma
Antibody-Cytokine Combinations With Philogen's Dr. Dario Neri
Fibroblasts In Regenerative Medicine with FibroBiologics' Pete O'Heeron & Dr. Hamid Khoja
Pyxis Oncology's Lara Sullivan, M.D. On Site-Specific ADCs And Change Management
The Biotech Beatdown With Allan Shaw
Inflammation & Antibodies with Ampio Pharmaceuticals' Mike Martino, CEO
What's Next For COVID Vaccines With Tonix Pharmaceuticals' Seth Lederman, M.D.
Running Interference: RNAi with Silence Therapeutics' Craig Tooman
Live Biologics & The Microbiome With 4D pharma's Duncan Peyton
Gene Tx For Renal Disease With Purespring CEO Richard Francis
Fighting Blindness & Funding The Fight With Opus Genetics' CEO Ben Yerxa, Ph.D.
Gynecological Cancer Therapies with Context Therapeutics' Martin Lehr
Commensal Viral Vectors with Ring Therapeutics' Tuyen Ong, M.D.
Antibodies For Severe Allergies With IgGenix's Jessica Grossman, M.D.
Gene Therapies For Ocular Disease With Sparing Vision's Stéphane Boissel
Biotech M&A Trends With Allan Shaw
Lipid Nanoparticle Gene Coding With SalioGen Therapeutics' Ray Tabibiazar, M.D.
CAR T-cells For Ovarian Cancer with Anixa Biosciences' Amit Kumar, Ph.D.
AI-Driven Biologics With Fountain Therapeutics' William Greene, M.D
Regulatory Harmonization With Aurion Biotech's Dr. Daniela Drago
Plant-Based Biologics With iBio's Randy Maddux
NK Cell Therapy Accessibility With Shoreline Biosciences' Dr. Kleanthis Xanthopoulos
A Hybrid mAb Manufacturing Model With John Glasspool
Biotech Capital Markets Forecast With Allan Shaw
Venture Philanthropy For Type 1 Diabetes With T1D Fund's Katie Ellias
Precision Approach To Infectious Disease With Locus Biosciences' Paul Garofolo
Bioengineering Human Tissue With Humacyte's Dr. Heather Prichard
The Top Stories Of 2021 With Allan Shaw
Complete CAR T Manufacturing Control with Cellectis' Steve Doares
Genomically-Guided Medicine with Elevation Oncology's Shawn Leland, PharmD, RPh
Inhalable mAbs & Vaccines with TFF's Glenn Mattes
Democratizing Biologics With Lumen Bioscience's Brian Finrow, J.D. & Craig Behnke, Ph.D.
Cornering The Antibody Market With Akesobio CEO Dr. Michelle Xia, Ph.D.
Turning The Liver Into A mAb Factory With Homology's Arthur Tzianabos, Ph.D.
Maximizing mRNA With Precision Nanosystems' James Taylor, Ph.D.
Foundations Of Flexible Manufacturing With Sarepta Therapeutics' Brian Winstead
The CDMO Capacity Crunch With Discovery Labs' Audrey Greenberg and Iovance Biotherapeutics' Sumit Verma
The Clinical Trials Conundrum with Allan Shaw
CMC Developability Assessments For Rapid Ph.1 Entry with AltruBio's Gene Lee, Ph.D.
CDMO With A Pipeline with Forge Biologics President & CEO Dr. Timothy J. Miller
Building A DNA Delivery System With Poseida Tx CEO Eric Ostertag, M.D., Ph.D.
From Bayer To Startup Bio With AltruBio's Dr. Judy Chou
Creating Competitive Differentiation With Allan Shaw
Gene Therapy Manufacturing Advances With Aruvant CTO Dr. Palani Palaniappan
iNK T-Cell Immuno-oncology For Solid Tumors With Dr. Ian Walters
How to Apply For BTD And Win It With Drs. Ira Gupta & Shanthi Ganeshan
Cold Chain Integrity & Sustainability With Celyad Oncology's Thomas Lequertier
Peptides & Proteins: Resetting The Immune System With Revolo CEO Jonathan Rigby
Intranasal Prophylactics For Flu & Coronavirus With Leyden Labs' Koenraad Weidhaup
Unpacking the SPAC With Allan Shaw
A Vaccine For Type 1 Diabetes With Diamyd Medical's Dr. Ulf Hannelius
CAR T Process Automation With Kite Pharma's Charles Calderaro III
Biopharma PR 101 with Matt Middleman, M.D.
A Scale-Up Story with Solis BioDyne Drs. Kadri Artma and Angela Vaasa
Academia + Industry with BridgeBio's Dr. Michael Henderson
GSK's Michael Mehler On The Cell & Gene Talent Crunch
RNA-Engineered Cell Therapy with Cartesian's Dr. Murat Kalayoglu
Real-Time Clinical Analysis with Glympse Bio's Dr. Caroline Loew
AAV & Lentivirus Gene Therapies with Sio Gene Therapeutics' Dr. Pavan Cheruvu
Med Device Meets Biopharma with OncoSec's Dan O'Connor, J.D.
Drug Development: From Bench To Bedside With Allan Shaw
Digital Transformation In Cell Therapy with Organicell Drs. Mari Mitrani & Michael Bellio
Biopharma Regulatory Requirements with bluebird bio's Scott Cleve
Filling A Vaccine Void with Cue Biopharma's Dan Passeri, J.D.
Supercharging An ADC Program With SOTIO CEO Dr. Radek Špíšek
mAb Manufacturing with Rezolute Bio CEO Nevan Charles Elam, JD
Cell Therapy Platforms With Precigen CEO Dr. Helen Sabzevari
A CFO's Prescription For Biopharma Success With Allan Shaw
A Biopharma Pivot with Compugen's Dr. Anat Cohen-Dayag
Preparing For The Clinic With Amolyt Pharma CEO Dr. Thierry Abribat
Pioneering Antiviral Conjugates with Cidara's Dr. Jeff Stein
AI & The Human Genome With Dr. Dietrich Stephan
The FDA's Progressive Appeal ft. Allan Shaw
Celyad CEO Filippo Petti On In-House Allogeneic Cell Therapy Manufacturing
Keeping Cell Therapy Clinicals On The Rails With Brian Culley
Orchard Tx's Bobby Gaspar On Manufacturing Hematopoietic Stem Cells
Acepodia's Approach To ACC & CAR Manufacturing Scalability
The AAV Vector Challenge With Selecta's Dr. Carsten Brunn
A Look Behind, A Look Ahead With Allan Shaw
Manipulating Milestones In Pandemic Times With AGTC's Sue Washer
Gene Therapy Manufacturing At-Scale With Geoff MacKay
Bacterial Therapy: Modulation of the Microbiome With Dr. Bernat Olle
Foundations Of Biopharma Finance With Smital Shah
Off-The-Shelf CAR T-Cell Therapy with John McKearn, Ph.D.
CAR T Therapy Cost Control With Laurence Cooper, M.D., Ph.D.
010: Gap Analysis With Dr. Pablo Valenzuela & Cristián Hernández-Cuevas
009: CMC Considerations For In-Human Studies with Drs. Edith Perez & Nathan Ihle
008: Commitment To GMP With Dr. Shabbir Anik
007: Quality Data For FDA Submissions With Dr. Robert Hariri
Summer Sessions 8: Dr. Gaurav Shah, Rocket's Chief Gene Therapist & Virtuoso
Summer Sessions 7: Dr. Randall Schatzman & The New Fundraising Norm
Summer Sessions 6: Alexis Peyroles On Myeloid Cells, Transplants, & Immuno-Oncology Inspiration
Summer Sessions 5: Dr. Christopher Anzalone Takes RNAi Beyond The Liver
Summer Sessions 4: Dr. Loretta Itri On Taking ADCs Across The Finish Line
Summer Sessions 3: Jeff Wolf Builds Heat Bio On Its Therapeutic Platform
Summer Sessions 2: Dr. Paul Wotton Solves A COVID-19 Workforce Crisis
Summer Sessions 1: Ivor Macleod brings big-league finance experience to an emerging biotech
006: Leaving The Incubator With Kavitha Iyer Rodrigues
005: Building A Biotech All-Star Team With Vivek Ramaswamy
004: Finding Funding In Volatile Times With Dr. Ben Zeskind
003: Building The Biopharma Pitch With Leslie Williams
002: The Biopharma Exit Strategy With Dr. Francois Nader
001: The Business Of Biotech: Allan Shaw
Business Of Biotech Trailer